Analyst Cove rage Update on EnteroMedics Inc. (NAS
Post# of 23069
Posted On: 11/30/2016 11:53:41 AM
Analyst Cove rage Update on EnteroMedics Inc. (NASDAQ:ETRM)
EnteroMedics Inc. (NASDAQ:ETRM) shares currently have a mean rating of 2.50 while 1 analysts have recommended the shares as ‘BUY’, 0 commented as ‘OUTPERFORM’ and 1 commented as ‘HOLD’. The rating score is on a scale of 1-5 where 1 stands for strong buy and 5 stands for sell. The mean price target for the company’s stock is $1.10 while the highest price target suggested by the analysts is $2.00 and low price target is $0.20. The mean price target is calculated keeping in view the consensus of 2 brokerage firms.
EnteroMedics Inc.(ETRM) has a mean revenue estimate for the ongoing quarter ending Dec 16 of $380k, according to 2 analysts. The average forecast of sales for the year ending Dec 16 is $1.19M by 2 analysts.
EnteroMedics Inc. went up 4.41% during trading on 11/30/2016, reaching at $0.07. The stock had a trading capacity of 267.39TH shares. The firm has a SMA 50 (Simple Moving Average) of -26.98% and a SMA 200-(Simple Moving Average) of -84.47% . This appreciation has taken its current market value to 7.67M. Shares registered one year high at $2.85 and the one year low of $0.04.
Earnings Overview For EnteroMedics Inc. (NASDAQ:ETRM)
Company latest quarter ended on 30 Sep 2016. There were earnings of $-0.17 per share. The reported earnings topped the analyst’s consensus by $0.33 with the surprise factor of 66.00%.
EnteroMedics Inc. (NASDAQ:ETRM) shares currently have a mean rating of 2.50 while 1 analysts have recommended the shares as ‘BUY’, 0 commented as ‘OUTPERFORM’ and 1 commented as ‘HOLD’. The rating score is on a scale of 1-5 where 1 stands for strong buy and 5 stands for sell. The mean price target for the company’s stock is $1.10 while the highest price target suggested by the analysts is $2.00 and low price target is $0.20. The mean price target is calculated keeping in view the consensus of 2 brokerage firms.
EnteroMedics Inc.(ETRM) has a mean revenue estimate for the ongoing quarter ending Dec 16 of $380k, according to 2 analysts. The average forecast of sales for the year ending Dec 16 is $1.19M by 2 analysts.
EnteroMedics Inc. went up 4.41% during trading on 11/30/2016, reaching at $0.07. The stock had a trading capacity of 267.39TH shares. The firm has a SMA 50 (Simple Moving Average) of -26.98% and a SMA 200-(Simple Moving Average) of -84.47% . This appreciation has taken its current market value to 7.67M. Shares registered one year high at $2.85 and the one year low of $0.04.
Earnings Overview For EnteroMedics Inc. (NASDAQ:ETRM)
Company latest quarter ended on 30 Sep 2016. There were earnings of $-0.17 per share. The reported earnings topped the analyst’s consensus by $0.33 with the surprise factor of 66.00%.
(0)
(0)
I'm in it to win it!
NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'
NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'